Stealth’s Elamipretide Gets US FDA Panel Nod, But Not A Glowing Endorsement, For Barth Syndrome

 
• By Sue Sutter
  
Building blocks
Stealth's elamipretide is a step closer to US FDA approval. • Source: Shutterstock

More from US FDA Performance Tracker

More from US Advisory Committees